Related Experiment Video
Updated: Apr 26, 2026

Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
Brief intervention for inappropriate z-hypnotics use in older adults: a before and after intervention study in
Tahreem Ghazal Siddiqui1, Tone Helene Breines Simonsen1, Maria Lie Selle1
1Health Services Research Unit (HØKH), Akershus University Hospital, Lørenskog, Norway.
Background:
Z-hypnotics are commonly prescribed for insomnia, but their use in older adults is associated with an increased risk of adverse events.
Aim:
We examined the long-term effect of brief intervention (BI) for inappropriate z-hypnotic use, where the control group crossed over to receive the BI 6 months after baseline.
Design And Setting:
A before-and-after intervention study was conducted in general practice. Older patients received the BI from trained general practitioners.
Method:
The BI group and the business-as-usual (BAU) group received the intervention with a six-month delay. The primary outcome: proportion of participants without inappropriate z-hypnotic use (≥4 weeks of use, ≥3 times per week). Secondary outcomes: the Global Sleep Assessment Questionnaire (GSAQ), pain visual analogue scale (VAS), Montreal Cognitive Assessment (MOCA), and Hospital Anxiety and Depression Scale (HADS). Patients were assessed at baseline, 6 weeks, 6 months, and 12 months.
Results:
We included 45 patients (31 female, mean age 69.4 years) and 21 GPs in the study. We found a significant reduction in inappropriate z-hypnotic use from baseline (68.9%) to post-treatment (27.78%), OR = 0.16, 95% CI: 0.04, 0.65, p = 0.01. GSAQ-insomnia score stayed low throughout the study. At 6 months, no participant reported insomnia. HADS was significantly reduced from baseline (mean 10.1) to post-intervention (mean 7.3, Cohen's d = -0.44, p < 0.01), whereas MOCA and VAS pain did not change significantly from baseline to post-intervention.
Conclusion:
The proportion of patients with inappropriate z-hypnotic use decreased after BI without negatively affecting sleep, mood, pain, or cognitive function..
Trial Registration:
clinicaltrials.gov (NCT06032715).
More Related Videos
Related Concept Videos
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
CNS Depressants: Barbiturates and Benzodiazepines
Management of Insomnia

